Profile data is unavailable for this security.
About the company
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
- Revenue in USD (TTM)4.34bn
- Net income in USD850.00m
- Incorporated2000
- Employees8.60k
- LocationIllumina Inc5200 Illumina WaySAN DIEGO 92122United StatesUSA
- Phone+1 (302) 658-7581
- Fax+1 (302) 655-5049
- Websitehttps://www.illumina.com
More ▼
Mergers & acquisitions
| Acquired company | ILMN:NSQ since announced | Transaction value |
|---|---|---|
| Somalogic Inc | 43.34% | 425.00m |
Data delayed at least 15 minutes, as of Mar 03 2026 18:05 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guardant Health Inc | 982.02m | -416.28m | 12.10bn | 2.49k | -- | -- | -- | 12.32 | -3.31 | -3.31 | 7.83 | -0.7602 | 0.5613 | 4.45 | 7.92 | 394,385.90 | -23.79 | -25.70 | -28.02 | -28.93 | 64.46 | 63.20 | -42.39 | -76.30 | 4.56 | -- | 1.07 | -- | 32.88 | 27.92 | 4.61 | -- | -2.23 | -- |
| Solventum Corp | 8.33bn | 1.56bn | 12.66bn | 20.00k | 8.23 | 2.51 | 6.19 | 1.52 | 8.87 | 8.87 | 47.48 | 29.10 | 0.5791 | 3.81 | 8.01 | 416,250.00 | 10.82 | -- | 13.58 | -- | 53.57 | 56.92 | 18.69 | 15.05 | 0.8906 | 2.05 | 0.4993 | -- | 0.8602 | 2.72 | 224.84 | 6.46 | 6.94 | -- |
| Globus Medical Inc | 2.94bn | 537.87m | 12.69bn | 6.00k | 23.84 | 2.77 | 15.55 | 4.32 | 3.93 | 3.93 | 21.44 | 33.86 | 0.5569 | 1.35 | 4.75 | 489,821.80 | 10.19 | 6.18 | 11.69 | 6.89 | 67.41 | 66.20 | 18.30 | 12.25 | 2.74 | -- | 0.0002 | 0.00 | 16.65 | 30.08 | 422.28 | 39.37 | 22.34 | -- |
| Penumbra Inc | 1.40bn | 177.69m | 13.43bn | 4.70k | 75.68 | 9.41 | 68.83 | 9.57 | 4.52 | 4.52 | 35.73 | 36.39 | 0.8356 | 1.10 | 7.85 | 298,652.10 | 10.58 | 4.03 | 11.77 | 4.49 | 67.14 | 64.57 | 12.66 | 5.39 | 4.29 | -- | 0.0159 | 0.00 | 17.50 | 20.16 | 1,168.11 | -- | 20.82 | -- |
| Align Technology Inc | 4.03bn | 410.35m | 13.47bn | 20.29k | 33.40 | 3.33 | 20.80 | 3.34 | 5.66 | 5.66 | 55.59 | 56.74 | 0.6483 | 5.33 | 3.85 | 198,864.70 | 6.59 | 8.11 | 9.67 | 11.97 | 68.27 | 70.62 | 10.17 | 12.31 | 1.24 | -- | 0.00 | 0.00 | 0.899 | 10.30 | -2.61 | -25.40 | -7.94 | -- |
| Cooper Companies Inc | 4.09bn | 374.90m | 16.37bn | 15.00k | 44.79 | 2.00 | 21.77 | 4.00 | 1.87 | 1.87 | 20.46 | 42.06 | 0.3312 | 1.71 | 5.29 | 272,826.70 | 3.03 | 8.04 | 3.32 | 8.86 | 65.54 | 66.01 | 9.16 | 24.66 | 1.13 | 6.32 | 0.2332 | 0.2049 | 5.06 | 10.98 | -4.44 | 9.48 | 3.15 | -- |
| Hologic Inc | 4.13bn | 543.80m | 16.84bn | 7.07k | 31.31 | 3.21 | 20.07 | 4.08 | 2.41 | 2.41 | 18.28 | 23.51 | 0.4608 | 2.57 | 6.79 | 583,663.40 | 6.07 | 11.22 | 6.82 | 12.85 | 56.51 | 60.20 | 13.18 | 21.99 | 3.32 | 15.76 | 0.3246 | 0.00 | 1.74 | 1.66 | -28.35 | -12.69 | -0.5168 | -- |
| Insulet Corp | 2.71bn | 247.10m | 17.28bn | 5.40k | 70.12 | 11.40 | 51.18 | 6.38 | 3.50 | 3.50 | 37.86 | 21.53 | 0.8628 | 1.74 | 6.14 | 501,518.50 | 7.87 | 7.14 | 9.75 | 8.51 | 71.63 | 68.72 | 9.13 | 10.06 | 2.15 | 46.91 | 0.3852 | 0.00 | 30.73 | 24.53 | -40.93 | 105.15 | 5.67 | -- |
| West Pharmaceutical Services Inc | 3.07bn | 493.70m | 18.10bn | 10.80k | 36.98 | 5.70 | 27.81 | 5.89 | 6.79 | 6.79 | 42.28 | 44.11 | 0.7769 | 4.80 | 5.40 | 284,638.90 | 12.11 | 15.24 | 14.29 | 18.19 | 35.91 | 37.89 | 15.59 | 18.67 | 2.34 | -- | 0.0614 | 10.13 | 6.25 | 7.44 | 0.203 | 7.36 | 10.39 | 5.51 |
| Zimmer Biomet Holdings Inc | 8.23bn | 704.60m | 19.47bn | 17.00k | 28.06 | 1.53 | 10.82 | 2.36 | 3.55 | 3.55 | 41.44 | 64.95 | 0.3703 | 1.10 | 5.17 | 484,211.80 | 3.17 | 3.03 | 3.58 | 3.46 | 69.71 | 71.01 | 8.56 | 9.10 | 1.10 | 4.71 | 0.3718 | 29.26 | 7.20 | 6.08 | -21.98 | -- | 9.26 | 0.00 |
| Illumina Inc | 4.34bn | 850.00m | 20.32bn | 8.60k | 24.26 | 7.47 | 18.14 | 4.68 | 5.48 | 5.48 | 27.88 | 17.80 | 0.6709 | 2.61 | 5.34 | 505,000.00 | 13.13 | -10.15 | 17.32 | -12.15 | 66.61 | 65.39 | 19.57 | -23.18 | 1.72 | 15.79 | 0.4221 | -- | -0.6633 | 6.04 | 169.50 | 5.32 | -4.77 | -- |
| Steris PLC | 5.83bn | 708.66m | 24.30bn | 17.79k | 34.48 | 3.40 | 20.30 | 4.17 | 7.19 | 7.18 | 59.09 | 72.93 | 0.5658 | 4.92 | 6.12 | 327,662.40 | 6.91 | 5.04 | 7.59 | 5.51 | 44.11 | 43.75 | 12.21 | 10.69 | 1.75 | 20.99 | 0.2094 | 37.51 | 6.24 | 12.49 | 10.64 | 8.40 | 11.52 | 8.99 |
| DexCom Inc | 4.66bn | 836.30m | 28.40bn | 11.00k | 35.71 | 10.34 | 26.10 | 6.09 | 2.07 | 2.07 | 11.50 | 7.14 | 0.727 | 3.02 | 4.20 | 423,818.20 | 13.04 | 8.85 | 21.58 | 12.58 | 62.09 | 63.92 | 17.94 | 14.21 | 1.59 | -- | 0.3204 | -- | 15.60 | 19.33 | 45.14 | 8.75 | 12.81 | -- |
| Veeva Systems Inc | 3.08bn | 860.33m | 29.83bn | 7.29k | 35.29 | 4.24 | 33.14 | 9.68 | 5.14 | 5.14 | 18.41 | 42.84 | 0.4234 | -- | 9.15 | 422,472.40 | 11.83 | 11.33 | 13.50 | 14.35 | 75.67 | 72.60 | 27.93 | 23.96 | -- | -- | 0.00 | 0.00 | 16.20 | 19.99 | 35.84 | 18.85 | 36.56 | -- |
Data as of Mar 03 2026. Currency figures normalised to Illumina Inc's reporting currency: US Dollar USD
49.24%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Capital Research & Management Co. (World Investors)as of 31 Dec 2025 | 20.10m | 13.16% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 13.15m | 8.61% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 13.03m | 8.53% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 6.19m | 4.05% |
| AQR Capital Management LLCas of 31 Dec 2025 | 4.43m | 2.90% |
| Loomis, Sayles & Co. LPas of 31 Dec 2025 | 4.17m | 2.73% |
| WCM Investment Management LLCas of 31 Dec 2025 | 4.07m | 2.66% |
| Corvex Management LPas of 31 Dec 2025 | 3.83m | 2.51% |
| Sessa Capital IM LPas of 31 Dec 2025 | 3.40m | 2.23% |
| Geode Capital Management LLCas of 31 Dec 2025 | 2.87m | 1.88% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
